Predictors of pacing-induced cardiomyopathy in patients undergoing AV nodal ablation: insights from a Delphi process and retrospective cohort study.

IF 4.3
European heart journal open Pub Date : 2026-06-29 eCollection Date: 2026-05-01 DOI:10.1093/ehjopen/oeag102
Nikola Kozhuharov, Anna Maria Gstoehl, Peter Calvert, Ioanna Koniari, Ali Najm, Mark T Mills, Kaung Thu, Panagiotis Xydis, Raphael Usteri, Agnieszka Babinska, Andreas Haeberlin, Tobias Reichlin, Christian Sticherling, Haran Burri, David Justin Wright, Archana Rao, Dhiraj Gupta
{"title":"Predictors of pacing-induced cardiomyopathy in patients undergoing AV nodal ablation: insights from a Delphi process and retrospective cohort study.","authors":"Nikola Kozhuharov, Anna Maria Gstoehl, Peter Calvert, Ioanna Koniari, Ali Najm, Mark T Mills, Kaung Thu, Panagiotis Xydis, Raphael Usteri, Agnieszka Babinska, Andreas Haeberlin, Tobias Reichlin, Christian Sticherling, Haran Burri, David Justin Wright, Archana Rao, Dhiraj Gupta","doi":"10.1093/ehjopen/oeag102","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Pacing-induced cardiomyopathy (PICM) is a recognized complication of pace-and-ablate therapy. Early identification of patients at risk may allow tailored strategies, including upfront biventricular or conduction system pacing.</p><p><strong>Purpose: </strong>This study aimed to identify predictors of PICM in patients undergoing pace-and-ablate therapy, combining expert consensus with clinical validation.</p><p><strong>Methods and results: </strong>A three-round Delphi process involving 12 electrophysiologists prioritized candidate predictors of PICM. Consecutive patients undergoing atrioventricular node ablation with non-cardiac resynchronization therapy (CRT) devices at Liverpool Heart and Chest Hospital (2015-2019) were retrospectively analysed. The primary endpoint was PICM, defined as ≥10% reduction in left ventricular ejection fraction (LVEF) to <50%, adjudicated by two independent cardiologists. Cox regression was used to identify independent predictors. The Delphi process prioritized baseline LVEF, intrinsic and paced QRS duration, RV lead position, and key comorbidities. Among 658 ablation patients, 323 (median age 76 years, 67% female) had non-CRT devices. Over a median follow-up of 192 days (IQR, 63-1003 days), 33 patients (9.8%) developed PICM. In multivariable analysis, RV free wall vs. septal lead position [hazard ratio (HR) 4.896, 95% confidence interval (CI) 1.263-18.973, <i>P</i> = 0.022], intrinsic QRS duration (HR 1.247 per 10 ms, 95% CI 1.064-1.462, <i>P</i> = 0.006), independently predicted PICM. Exploratory analyses suggested that higher intrinsic QRS duration was associated with increased PICM risk; however, these findings were based on a small number of events and should be interpreted with caution.</p><p><strong>Conclusion: </strong>Intrinsic QRS duration and free wall RV lead position independently predict PICM in pace-and-ablate patients. These findings support early risk stratification and may guide personalized pacing strategies.</p>","PeriodicalId":93995,"journal":{"name":"European heart journal open","volume":"6 3","pages":"oeag102"},"PeriodicalIF":4.3000,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13312120/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European heart journal open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjopen/oeag102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Pacing-induced cardiomyopathy (PICM) is a recognized complication of pace-and-ablate therapy. Early identification of patients at risk may allow tailored strategies, including upfront biventricular or conduction system pacing.

Purpose: This study aimed to identify predictors of PICM in patients undergoing pace-and-ablate therapy, combining expert consensus with clinical validation.

Methods and results: A three-round Delphi process involving 12 electrophysiologists prioritized candidate predictors of PICM. Consecutive patients undergoing atrioventricular node ablation with non-cardiac resynchronization therapy (CRT) devices at Liverpool Heart and Chest Hospital (2015-2019) were retrospectively analysed. The primary endpoint was PICM, defined as ≥10% reduction in left ventricular ejection fraction (LVEF) to <50%, adjudicated by two independent cardiologists. Cox regression was used to identify independent predictors. The Delphi process prioritized baseline LVEF, intrinsic and paced QRS duration, RV lead position, and key comorbidities. Among 658 ablation patients, 323 (median age 76 years, 67% female) had non-CRT devices. Over a median follow-up of 192 days (IQR, 63-1003 days), 33 patients (9.8%) developed PICM. In multivariable analysis, RV free wall vs. septal lead position [hazard ratio (HR) 4.896, 95% confidence interval (CI) 1.263-18.973, P = 0.022], intrinsic QRS duration (HR 1.247 per 10 ms, 95% CI 1.064-1.462, P = 0.006), independently predicted PICM. Exploratory analyses suggested that higher intrinsic QRS duration was associated with increased PICM risk; however, these findings were based on a small number of events and should be interpreted with caution.

Conclusion: Intrinsic QRS duration and free wall RV lead position independently predict PICM in pace-and-ablate patients. These findings support early risk stratification and may guide personalized pacing strategies.

房室结消融患者起搏诱发心肌病的预测因素:德尔菲过程和回顾性队列研究的见解。
目的:起搏性心肌病(PICM)是公认的起搏消融治疗的并发症。早期识别有风险的患者可能允许量身定制的策略,包括预先双室或传导系统起搏。目的:本研究旨在结合专家共识和临床验证,确定接受步伐消融治疗的患者PICM的预测因素。方法和结果:由12名电生理学家参与的三轮德尔菲过程优先考虑了PICM的候选预测因子。回顾性分析2015-2019年在利物浦心胸医院连续行房室结消融非心脏再同步化治疗(CRT)装置的患者。主要终点是PICM,定义为左室射血分数(LVEF)降低≥10% (P = 0.022),内在QRS持续时间(HR 1.247 / 10 ms, 95% CI 1.064-1.462, P = 0.006)独立预测PICM。探索性分析表明,内在QRS持续时间越长,PICM风险越高;然而,这些发现是基于少数事件,应该谨慎解释。结论:内在QRS持续时间和游离壁RV导联位置可独立预测起搏消融患者的PICM。这些发现支持早期风险分层,并可能指导个性化的起搏策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书